Daniel Mark Wechsler - Net Worth and Insider Trading
Daniel Mark Wechsler Net Worth
The estimated net worth of Daniel Mark Wechsler is at least $1,100 dollars as of 2024-11-05. Daniel Mark Wechsler is the See Remarks of Melinta Therapeutics Inc and owns about 10,000 shares of Melinta Therapeutics Inc (MLNTQ) stock worth over $1,100. Details can be seen in Daniel Mark Wechsler's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel Mark Wechsler has not made any transactions after 2018-05-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Daniel Mark Wechsler
Daniel Mark Wechsler Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel Mark Wechsler owns 2 companies in total, including Melinta Therapeutics Inc (MLNTQ) , and Bausch Health Companies Inc (BHC) .
Click here to see the complete history of Daniel Mark Wechsler’s form 4 insider trades.
Insider Ownership Summary of Daniel Mark Wechsler
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MLNTQ | Melinta Therapeutics Inc | 2018-06-12 | director & See Remarks |
| BHC | Bausch Health Companies Inc | 2013-08-07 | EVP & Company Group Chairman |
Daniel Mark Wechsler Latest Holdings Summary
Daniel Mark Wechsler currently owns a total of 1 stock. Daniel Mark Wechsler owns 10,000 shares of Melinta Therapeutics Inc (MLNTQ) as of May 29, 2018, with a value of $1,100.
Latest Holdings of Daniel Mark Wechsler
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MLNTQ | Melinta Therapeutics Inc | 2018-05-29 | 10,000 | 0.11 | 1,100 |
Holding Weightings of Daniel Mark Wechsler
Daniel Mark Wechsler Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel Mark Wechsler has made a total of 0 transactions in Melinta Therapeutics Inc (MLNTQ) over the past 5 years. The most-recent trade in Melinta Therapeutics Inc is the acquisition of 10,000 shares on May 29, 2018, which cost Daniel Mark Wechsler around $250,000.
Insider Trading History of Daniel Mark Wechsler
- 1
Daniel Mark Wechsler Trading Performance
GuruFocus tracks the stock performance after each of Daniel Mark Wechsler's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel Mark Wechsler is -26.98%. GuruFocus also compares Daniel Mark Wechsler's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel Mark Wechsler within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Daniel Mark Wechsler's insider trading performs compared to the benchmark.
Performance of Daniel Mark Wechsler
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.79 | | | | | |
| Relative Return to S&P 500(%) | -0.27 | | | | | |
Daniel Mark Wechsler Ownership Network
Ownership Network List of Daniel Mark Wechsler
Ownership Network Relation of Daniel Mark Wechsler
Daniel Mark Wechsler Owned Company Details
What does Melinta Therapeutics Inc do?
Who are the key executives at Melinta Therapeutics Inc?
Daniel Mark Wechsler is the director & See Remarks of Melinta Therapeutics Inc. Other key executives at Melinta Therapeutics Inc include director & Chief Executive Officer John Johnson , Chief Commercial Officer John Temperato , and director & President and CEO Prabhavathi Fernandes .
Melinta Therapeutics Inc (MLNTQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Melinta Therapeutics Inc (MLNTQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Melinta Therapeutics Inc (MLNTQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Melinta Therapeutics Inc (MLNTQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Melinta Therapeutics Inc Insider Transactions
Daniel Mark Wechsler Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel Mark Wechsler. You might contact Daniel Mark Wechsler via mailing address: 2150 St. Elzear Blvd. West, Laval A8 H7l 4a8.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
